For at least the second time this year, a major pharma company has filed suit against a competitor to halt promotional material suggesting its products are inferior.
This time, GlaxoSmithKline PLC is seeking to stop a marketing campaign by Boehringer Ingelheim Pharmaceuticals Inc. for its...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?